Vitrolife AB (publ)

Stockholm Stock Exchange VITR.ST

Vitrolife AB (publ) Current Liabilities for the year ending December 31, 2023: USD 54.98 M

Vitrolife AB (publ) Current Liabilities is USD 54.98 M for the year ending December 31, 2023, a -7.30% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Vitrolife AB (publ) Current Liabilities for the year ending December 31, 2022 was USD 59.31 M, a -43.56% change year over year.
  • Vitrolife AB (publ) Current Liabilities for the year ending December 31, 2021 was USD 105.07 M, a 389.75% change year over year.
  • Vitrolife AB (publ) Current Liabilities for the year ending December 31, 2020 was USD 21.45 M, a -0.35% change year over year.
  • Vitrolife AB (publ) Current Liabilities for the year ending December 31, 2019 was USD 21.53 M, a 25.68% change year over year.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
SV Wall Street
Stockholm Stock Exchange: VITR.ST

Vitrolife AB (publ)

CEO Ms. Bronwyn Brophy O´Connor
IPO Date June 28, 2001
Location Sweden
Headquarters Gustaf Werners gata 2
Employees 1,111
Sector Healthcare
Industries
Biotechnology 3D Printing Clinical Trials Medical Instruments Plastics Robotics Satellite Telehealth
Description

Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.

StockViz Staff

February 6, 2025

Any question? Send us an email